158 related articles for article (PubMed ID: 33662192)
1. Association of thyroid autoimmunity and the response to recombinant human growth hormone in Turner syndrome.
Song Y; Yang H; Wang L; Gong F; Pan H; Zhu H
J Pediatr Endocrinol Metab; 2021 Apr; 34(4):465-471. PubMed ID: 33662192
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of autoantibodies associated with thyroid and celiac disease in Ullrich-Turner syndrome in relation to adult height after growth hormone treatment.
Bettendorf M; Doerr HG; Hauffa BP; Lindberg A; Mehls O; Partsch CJ; Schwarz HP; Stahnke N; Ranke MB
J Pediatr Endocrinol Metab; 2006 Feb; 19(2):149-54. PubMed ID: 16562588
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of the influencing factors of recombinant human growth hormone effect in the children with Turner syndrome].
Li J; Wu W; Liang Y; Luo XP
Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):866-870. PubMed ID: 30392213
[No Abstract] [Full Text] [Related]
4. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT
Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651
[TBL] [Abstract][Full Text] [Related]
5. Endocrine autoimmunity in Turner syndrome.
Grossi A; Crinò A; Luciano R; Lombardo A; Cappa M; Fierabracci A
Ital J Pediatr; 2013 Dec; 39():79. PubMed ID: 24355069
[TBL] [Abstract][Full Text] [Related]
6. Thyroid Autoimmunity in Girls with Turner Syndrome.
Witkowska-Sędek E; Borowiec A; Kucharska A; Chacewicz K; Rumińska M; Demkow U; Pyrżak B
Adv Exp Med Biol; 2017; 1022():71-76. PubMed ID: 28456931
[TBL] [Abstract][Full Text] [Related]
7. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
Binder G; Baur F; Schweizer R; Ranke MB
J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
[TBL] [Abstract][Full Text] [Related]
8. The interactive effect of GHR-exon 3 and -202 A/C IGFBP3 polymorphisms on rhGH responsiveness and treatment outcomes in patients with Turner syndrome.
Braz AF; Costalonga EF; Montenegro LR; Trarbach EB; Antonini SR; Malaquias AC; Ramos ES; Mendonca BB; Arnhold IJ; Jorge AA
J Clin Endocrinol Metab; 2012 Apr; 97(4):E671-7. PubMed ID: 22278433
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone effect on body composition in Turner syndrome.
Baldin AD; Fabbri T; Siviero-Miachon AA; Spinola-Castro AM; de Lemos-Marini SH; Baptista MT; D'Souza-Li LF; Maciel-Guerra AT; Guerra-Junior G
Endocrine; 2011 Dec; 40(3):486-91. PubMed ID: 21720878
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety of recombinant human growth hormone in turner syndrome.
Bolar K; Hoffman AR; Maneatis T; Lippe B
J Clin Endocrinol Metab; 2008 Feb; 93(2):344-51. PubMed ID: 18000090
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune hypothyroidism and hyperthyroidism in patients with Turner's syndrome.
Chiovato L; Larizza D; Bendinelli G; Tonacchera M; Marinó M; Mammoli C; Lorini R; Severi F; Pinchera A
Eur J Endocrinol; 1996 May; 134(5):568-75. PubMed ID: 8664977
[TBL] [Abstract][Full Text] [Related]
12. Thyroid autoantibodies, Turner's syndrome and growth hormone therapy.
Ivarsson SA; Ericsson UB; Nilsson KO; Gustafsson J; Hagenäs L; Häger A; Moell C; Tuvemo T; Westphal O; Albertsson-Wikland K
Acta Paediatr; 1995 Jan; 84(1):63-5. PubMed ID: 7734902
[TBL] [Abstract][Full Text] [Related]
13. Effect of long-term recombinant growth hormone therapy in children--the National Cooperative Growth Study, USA, 1985-1994.
Root AW; Kemp SF; Rundle AC; Dana K; Attie KM
J Pediatr Endocrinol Metab; 1998; 11(3):403-12. PubMed ID: 11517956
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone in turner syndrome.
Khadilkar VV; Khadilkar AV; Nandy M; Maskati GB
Indian Pediatr; 2006 Mar; 43(3):236-40. PubMed ID: 16585818
[TBL] [Abstract][Full Text] [Related]
15. Effects of growth hormone on body proportions in Turner syndrome compared with non-treated patients and normal women.
Baldin AD; Fabbri T; Siviero-Miachon AA; Spinola-Castro AM; Lemos-Marini SH; Baptista MT; D'Souza-Li LF; Maciel-Guerra AT; Guerra G
J Endocrinol Invest; 2010 Nov; 33(10):691-5. PubMed ID: 20354352
[TBL] [Abstract][Full Text] [Related]
16. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
[TBL] [Abstract][Full Text] [Related]
17. Safety and Effectiveness of Omnitrope®, a Biosimilar Recombinant Human Growth Hormone: More Than 10 Years' Experience from the PATRO Children Study.
Pfäffle R; Bidlingmaier M; Kreitschmann-Andermahr I; Land C; Partsch CJ; Schwab KO; Sommer H; Backeljauw P; Kanumakala S; Loche S; Zouater H; Strasburger CJ
Horm Res Paediatr; 2020; 93(3):154-163. PubMed ID: 32814319
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of growth hormone combined with low-dose stanozolol on growth velocity and final height of girls with Turner syndrome.
Xiong H; Chen HS; Du ML; Li YH; Ma HM; Su Z; Chen QL
Clin Endocrinol (Oxf); 2015 Aug; 83(2):223-8. PubMed ID: 25824243
[TBL] [Abstract][Full Text] [Related]
19. Association of Turner Syndrome and Growth Hormone Deficiency: A Review.
Marques JS; Aires S
Pediatr Endocrinol Rev; 2015 Sep; 13(1):455-7. PubMed ID: 26540761
[TBL] [Abstract][Full Text] [Related]
20. [Rapidly progressive puberty in a patient with mosaic Turner syndrome: a case report and literature review].
Liang Y; Wei H; Yu X; Huang W; Luo XP
Zhonghua Er Ke Za Zhi; 2017 Feb; 55(2):125-130. PubMed ID: 28173651
[No Abstract] [Full Text] [Related]
[Next] [New Search]
